These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 28001043)

  • 1. Biological Insights of the Dopaminergic Stabilizer ACR16 at the Binding Pocket of Dopamine D2 Receptor.
    Ekhteiari Salmas R; Seeman P; Aksoydan B; Stein M; Yurtsever M; Durdagi S
    ACS Chem Neurosci; 2017 Apr; 8(4):826-836. PubMed ID: 28001043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopaminergic stabilizer ASP2314/ACR16 selectively interacts with D2(High) receptors.
    Seeman P; Tokita K; Matsumoto M; Matsuo A; Sasamata M; Miyata K
    Synapse; 2009 Oct; 63(10):930-4. PubMed ID: 19588469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus Docking.
    Salmas RE; Seeman P; Aksoydan B; Erol I; Kantarcioglu I; Stein M; Yurtsever M; Durdagi S
    ACS Chem Neurosci; 2017 Jun; 8(6):1404-1415. PubMed ID: 28272861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques.
    Durdagi S; Salmas RE; Stein M; Yurtsever M; Seeman P
    ACS Chem Neurosci; 2016 Feb; 7(2):185-95. PubMed ID: 26645629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Investigation of the Dopamine-2 Receptor Agonist Bromocriptine Binding to Dimeric D2
    Salmas RE; Seeman P; Stein M; Durdagi S
    J Chem Inf Model; 2018 Apr; 58(4):826-836. PubMed ID: 29537837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atomistic molecular dynamics simulations of typical and atypical antipsychotic drugs at the dopamine D2 receptor (D2R) elucidates their inhibition mechanism.
    Salmas RE; Yurtsever M; Durdagi S
    J Biomol Struct Dyn; 2017 Mar; 35(4):738-754. PubMed ID: 26923489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R).
    Ekhteiari Salmas R; Serhat Is Y; Durdagi S; Stein M; Yurtsever M
    J Biomol Struct Dyn; 2018 Aug; 36(10):2668-2677. PubMed ID: 28805144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D(2) receptor antagonism and fast receptor dissociation properties.
    Dyhring T; Nielsen EØ; Sonesson C; Pettersson F; Karlsson J; Svensson P; Christophersen P; Waters N
    Eur J Pharmacol; 2010 Feb; 628(1-3):19-26. PubMed ID: 19919834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
    McCormick PN; Kapur S; Seeman P; Wilson AA
    Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
    Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
    Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
    Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
    Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
    J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative MD Simulations Indicate a Dual Role for Arg1323.50 in Dopamine-Dependent D2R Activation.
    Kling RC; Clark T; Gmeiner P
    PLoS One; 2016; 11(1):e0146612. PubMed ID: 26741139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions.
    Salmas RE; Yurtsever M; Stein M; Durdagi S
    Mol Divers; 2015 May; 19(2):321-32. PubMed ID: 25652238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the actions of the novel dopamine receptor-directed compounds (S)-OSU6162 and ACR16 at the D2 dopamine receptor.
    Kara E; Lin H; Svensson K; Johansson AM; Strange PG
    Br J Pharmacol; 2010 Nov; 161(6):1343-50. PubMed ID: 20804495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the dopamine D
    Im D; Inoue A; Fujiwara T; Nakane T; Yamanaka Y; Uemura T; Mori C; Shiimura Y; Kimura KT; Asada H; Nomura N; Tanaka T; Yamashita A; Nango E; Tono K; Kadji FMN; Aoki J; Iwata S; Shimamura T
    Nat Commun; 2020 Dec; 11(1):6442. PubMed ID: 33353947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent haloperidol derivatives covalently binding to the dopamine D2 receptor.
    Schwalbe T; Kaindl J; Hübner H; Gmeiner P
    Bioorg Med Chem; 2017 Oct; 25(19):5084-5094. PubMed ID: 28666858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.
    Fu W; Shen J; Luo X; Zhu W; Cheng J; Yu K; Briggs JM; Jin G; Chen K; Jiang H
    Biophys J; 2007 Sep; 93(5):1431-41. PubMed ID: 17468175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
    Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).
    Pettersson F; Pontén H; Waters N; Waters S; Sonesson C
    J Med Chem; 2010 Mar; 53(6):2510-20. PubMed ID: 20155917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.